Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TEVA

Teva

$20.90

0.185 (0.89%)

, MYL

Mylan

$46.51

-0.27 (-0.58%)

11:30
01/19/18
01/19
11:30
01/19/18
11:30
Periodicals
DOJ official says U.S. may sue generic drugmakers, Bloomberg reports »

Bloomberg cites the…

TEVA

Teva

$20.90

0.185 (0.89%)

MYL

Mylan

$46.51

-0.27 (-0.58%)

ENDP

Endo

$7.35

-0.34 (-4.42%)

LCI

Lannett

$24.55

0.9 (3.81%)

PRGO

Perrigo

$91.03

-0.66 (-0.72%)

AKRX

Akorn

$33.06

-0.09 (-0.27%)

TARO

Taro Pharmaceutical

$104.99

-2.275 (-2.12%)

IPXL

Impax

$20.55

0.15 (0.74%)

NVS

Novartis

$86.47

0.06 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 08

    Feb

  • 16

    Feb

  • 01

    Mar

  • 02

    Mar

  • 08

    Mar

  • 23

    Apr

  • 17

    May

  • 21

    Jul

Yesterday
TEVA

Teva

$20.88

-0.6 (-2.79%)

13:06
01/18/18
01/18
13:06
01/18/18
13:06
Downgrade
Teva rating change  »

Follow-up: Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$20.81

-0.67 (-3.12%)

13:00
01/18/18
01/18
13:00
01/18/18
13:00
Downgrade
Teva rating change at BTIG »

Teva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$20.95

-0.535 (-2.49%)

, MYL

Mylan

$46.78

0.14 (0.30%)

11:34
01/18/18
01/18
11:34
01/18/18
11:34
Recommendations
Teva, Mylan, Impax, Novartis, Endo analyst commentary at Leerink »

Hospitals' entrant…

TEVA

Teva

$20.95

-0.535 (-2.49%)

MYL

Mylan

$46.78

0.14 (0.30%)

IPXL

Impax

$20.40

1.1 (5.70%)

NVS

Novartis

$86.43

-0.45 (-0.52%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 01

    Mar

  • 08

    Mar

  • 23

    Apr

  • 17

    May

ENDP

Endo

$7.69

-0.32 (-4.00%)

, IPXL

Impax

$20.40

1.1 (5.70%)

11:19
01/18/18
01/18
11:19
01/18/18
11:19
Recommendations
Endo, Impax, Mylan, Teva analyst commentary at Cantor Fitzgerald »

Report of hospital plans…

ENDP

Endo

$7.69

-0.32 (-4.00%)

IPXL

Impax

$20.40

1.1 (5.70%)

MYL

Mylan

$46.78

0.14 (0.30%)

TEVA

Teva

$20.83

-0.65 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 01

    Mar

  • 08

    Mar

TEVA

Teva

$20.63

-0.85 (-3.96%)

, MYL

Mylan

$46.78

0.14 (0.30%)

10:03
01/18/18
01/18
10:03
01/18/18
10:03
Periodicals
Hospitals plan nonprofit generic drug company, NY Times says »

Some of the…

TEVA

Teva

$20.63

-0.85 (-3.96%)

MYL

Mylan

$46.78

0.14 (0.30%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

NVS

Novartis

$86.53

-0.35 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

  • 23

    Apr

  • 17

    May

CTIC

CTI BioPharma

$3.41

-0.08 (-2.29%)

, TEVA

Teva

$21.48

0.07 (0.33%)

05:47
01/18/18
01/18
05:47
01/18/18
05:47
Hot Stocks
CTI BioPharma to receive $10M milestone payment from Teva for Trisenox »

CTI BioPharma (CTIC)…

CTIC

CTI BioPharma

$3.41

-0.08 (-2.29%)

TEVA

Teva

$21.48

0.07 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

Monday
TEVA

Teva

$22.07

0.33 (1.52%)

18:32
01/15/18
01/15
18:32
01/15/18
18:32
Hot Stocks
FDA approves Teva's Trisenox injection for Acute Promyelocytic Leukemia »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
TEVA

Teva

$22.13

0.385 (1.77%)

15:28
01/12/18
01/12
15:28
01/12/18
15:28
Recommendations
Teva analyst commentary at Wells Fargo »

Teva debt risk mostly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$22.17

0.43 (1.98%)

15:22
01/12/18
01/12
15:22
01/12/18
15:22
Hot Stocks
Moody's downgrades senior unsecured ratings of Teva to Ba2 »

Moody's Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.